Novartis Pharmaceuticals Corporation v. Handa Neuroscience, LLC et al > Summary
Court Case Number 1:22-cv-00352
Filing Date Mar 21, 2022
Termination Date Oct 26, 2022
Court Delaware District Court
Status Judgment - Judgment on Consent
JudgesGregory B. Williams
Plaintiff
Plaintiff Attorneys
10Novartis
Attorney Name: Alexandra M. Joyce
McCarter & English
Novartis
Attorney Name: Daniel M. Silver
McCarter & English
Novartis
Attorney Name: Andrew Philip Blythe
Gibson Dunn & Crutcher
Novartis
Attorney Name: Anne Y. Brody
Gibson Dunn & Crutcher
Novartis
Attorney Name: Aileen C. Huang
Gibson Dunn & Crutcher
Novartis
Attorney Name: Jane M. Love
Gibson Dunn & Crutcher
Novartis
Attorney Name: Emil N. Nachman
Gibson Dunn & Crutcher
Novartis
Attorney Name: Christine Ranney
Gibson Dunn & Crutcher
Novartis
Attorney Name: Robert W. Trenchard
Gibson Dunn & Crutcher
Novartis
Attorney Name: Sung Bin Lee
Gibson Dunn & Crutcher
Defendant Attorneys
6Handa Neuroscience, LLC
Attorney Name: John C. Phillips, Jr.
Phillips, McLaughlin & Hall, P.A.
Handa Pharmaceuticals
Attorney Name: David A. Bilson
Phillips, McLaughlin & Hall, P.A.
Handa Pharmaceuticals
Attorney Name: John C. Phillips, Jr.
Phillips, McLaughlin & Hall, P.A.
Handa Pharmaceuticals
Attorney Name: Don J. Mizerk
Husch Blackwell LLP
Handa Pharmaceuticals
Attorney Name: Stephen Cary
Handa Pharmaceuticals
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| 10543179 | Dosage regimen of an S1P receptor modulator | Jan 28, 2020 |
| 09187405 | S1P receptor modulators for treating relasping-remitting multiple sclerosis | Nov 17, 2015 |
